About Mstone

Mstone partners

Established in 2013, Mstone Healthcare Partners is an incubator of biotech, healthcare and AI companies. Mstone founds, staffs, develops, and grows portfolio companies by building upon novel technology as well as human and investment capital.

 

We believe that not all development is the same and whether in life sciences, healthcare or AI, our approach is to leverage technologies that address a demonstrated need, are well-positioned for growth and commercialization, and promise attractive market positions.

 

We believe in the power of partnership and, regardless of the industry, our portfolio companies all seek to affect transformational change by partnering, licensing, and co-developing our businesses and assets in an interest-aligned manner. We also efficiently manage capital deployment as we reach corporate milestones and create substantive inflection points to reflect significant economic value.

Polaryx Milestone

Forest Hills Lab

Forest Hills Lab

Drugs for the treatment of neurodegenerative conditions, including Parkinson’s, Alzheimer’s, and Huntington’s Diseases

Founded: 2017

Liberyx therapeutics

Liberyx therapeutics

Rare pediatric drugs for treatment of metabolic disorders such as non-ketonic hyperglycinemia, urea cycle disorders with IND approved in 2022

Founded: 2021

Humeryx pharmaceuticals

Humeryx pharmaceuticals

Drugs for the treatment of autoimmune diseases such as type 1 diabetes, rheumatoid arthritis, among others, currently in pre-clinical stage

Founded: 2020

fhl

fhl

Medical- and non-medical grade aesthetic products distributed globally with Korean R&D and manufacturing excellence

Founded: 2017

embrace healthcare lab

embrace healthcare lab

A platform developing smart AI technology to revolutionize healthcare delivery and management, focusing on the roll-out of an AI-powered B2B2C digital clinic app

Founded: 2024

Dr+ Kudos Lab

Dr+ Kudos Lab

An innovative aesthetic clinic franchise powered by AI technologies and distribution channels to build & grow a global franchise

Founded: 2024

We’re seeking partners to help bring Polaryx therapies to patients and families fighting lysosomal storage disorders.
Interested?